Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glucolive MV 1mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Allysia Lifesciences Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Glucolive MV 1mg/500mg/0.2mg Tablet

DiabetaComb 1mg/500mg/0.2mg tablets are classified as antidiabetic agents, a combination medication for managing type 2 diabetes in adults. This medication helps regulate blood glucose levels. DiabetaComb 1mg/500mg/0.2mg tablets should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan encompassing a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle modifications are paramount in diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms such as sweating, dizziness, headache, and tremors. Prompt recognition and treatment are essential; maintain regular meals and carry a rapid-acting glucose source. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Primary Ingredients of Glucolive MV 1mg/500mg/0.2mg Tablet

No text provided. Please provide the text you wish me to rephrase.

Uses of Glucolive MV 1mg/500mg/0.2mg Tablet

Managing type 2 diabetes

Major Benefits of Glucolive MV 1mg/500mg/0.2mg Tablet:

Consume Glucolive MV 1mg/500mg/0.2mg tablets precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer the medication on an empty stomach.

Common Side effects of Glucolive MV 1mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glucolive MV 1mg/500mg/0.2mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the Glucolive MV 1mg/500mg/0.2mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication on an empty stomach.

How Glucolive MV 1mg/500mg/0.2mg Tablet works:

Glucolive MV tablets (1mg/500mg/0.2mg) contain a triple-action formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Glucolive MV 1mg/500mg/0.2mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glucolive MV 1mg/500mg/0.2mg Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glucolive MV 1mg/500mg/0.2mg tablets while breastfeeding is potentially hazardous. Available human data indicate a possibility of the medication transferring to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Patients with kidney disease should likely avoid Glucolive MV 1mg/500mg/0.2mg Tablets due to potential safety concerns. Medical advice is recommended. The use of Glucolive MV 1mg/500mg/0.2mg Tablets is discouraged in individuals with severe kidney impairment.

LiverLiverCAUTION

Patients with liver impairment should use Glucolive MV 1mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Individuals with mild to moderate hepatic dysfunction should typically begin with a low dose; however, this medication is contraindicated in those with severe liver disease.

What if you forget to take Glucolive MV 1mg/500mg/0.2mg Tablet :

Should you forget a Glucolive MV 1mg/500mg/0.2mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glucolive MV 1mg/500mg/0.2mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Glucolive MV 1mg/500mg/0.2mg Tablet

Glucolive MV 1mg/500mg/0.2mg Tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers post-meal glucose levels. This medication is not suitable for type 1 diabetes.
Glucolive MV 1mg/500mg/0.2mg Tablets may cause common side effects including low blood sugar (hypoglycemia), nausea, diarrhea, altered taste perception, gas, stomach pain, headache, skin rash, and respiratory infections.
Glucolive MV 1mg/500mg/0.2mg Tablets are contraindicated in patients with allergies to its components or excipients, moderate-to-severe kidney disease, inflammatory bowel disease, colonic ulcers, and metabolic acidosis (including diabetic ketoacidosis).
Combining Glucolive MV 1mg/500mg/0.2mg tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glucolive MV 1mg/500mg/0.2mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glucolive MV 1mg/500mg/0....
156
MRP 180
13% off